- Home
- BLRX vs BREA Comparison
BLRX vs BREA Comparison
Compare BLRX & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- BREA
- Stock Information
- Founded
- BLRX 2003
- BREA 2022
- Country
- BLRX Israel
- BREA Ireland
- Employees
- BLRX N/A
- BREA N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- BLRX Health Care
- BREA Consumer Discretionary
- Exchange
- BLRX Nasdaq
- BREA Nasdaq
- Market Cap
- BLRX 10.3M
- BREA 8.7M
- IPO Year
- BLRX 2011
- BREA 2023
- Fundamental
- Price
- BLRX $2.93
- BREA $0.69
- Analyst Decision
- BLRX Buy
- BREA
- Analyst Count
- BLRX 2
- BREA 0
- Target Price
- BLRX $26.00
- BREA N/A
- AVG Volume (30 Days)
- BLRX 30.2K
- BREA 139.3K
- Earning Date
- BLRX 05-27-2025
- BREA 01-03-2025
- Dividend Yield
- BLRX N/A
- BREA N/A
- EPS Growth
- BLRX N/A
- BREA N/A
- EPS
- BLRX N/A
- BREA N/A
- Revenue
- BLRX $28,940,000.00
- BREA $2,872,101.00
- Revenue This Year
- BLRX N/A
- BREA N/A
- Revenue Next Year
- BLRX N/A
- BREA N/A
- P/E Ratio
- BLRX N/A
- BREA N/A
- Revenue Growth
- BLRX 502.92
- BREA 2338.69
- 52 Week Low
- BLRX $2.30
- BREA $0.50
- 52 Week High
- BLRX $35.60
- BREA $1.95
- Technical
- Relative Strength Index (RSI)
- BLRX 48.07
- BREA 53.35
- Support Level
- BLRX $2.30
- BREA $0.63
- Resistance Level
- BLRX $3.09
- BREA $0.70
- Average True Range (ATR)
- BLRX 0.22
- BREA 0.05
- MACD
- BLRX 0.06
- BREA -0.00
- Stochastic Oscillator
- BLRX 79.33
- BREA 42.55
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.